These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 2591017
1. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Witschi H, Kennedy AR. Carcinogenesis; 1989 Dec; 10(12):2275-7. PubMed ID: 2591017 [Abstract] [Full Text] [Related]
2. Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC). Witschi H, Espiritu I. Cancer Lett; 2002 Sep 26; 183(2):141-6. PubMed ID: 12065088 [Abstract] [Full Text] [Related]
3. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice. Kennedy AR, Kritchevsky D, Shen WC. Pharm Res; 2003 Dec 26; 20(12):1908-10. PubMed ID: 14725352 [Abstract] [Full Text] [Related]
4. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor. St Clair WH. Carcinogenesis; 1991 May 26; 12(5):935-7. PubMed ID: 2029760 [Abstract] [Full Text] [Related]
5. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent. Ekrami H, Kennedy AR, Witschi H, Shen WC. J Drug Target; 1993 May 26; 1(1):41-9. PubMed ID: 8069543 [Abstract] [Full Text] [Related]
6. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Kennedy AR. Am J Clin Nutr; 1998 Dec 26; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508 [Abstract] [Full Text] [Related]
7. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice. Suzuki K, Yano T, Sadzuka Y, Sugiyama T, Seki T, Asano R. Oncol Rep; 2005 Jun 26; 13(6):1247-50. PubMed ID: 15870950 [Abstract] [Full Text] [Related]
8. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. Ware JH, Wan XS, Newberne P, Kennedy AR. Dig Dis Sci; 1999 May 26; 44(5):986-90. PubMed ID: 10235608 [Abstract] [Full Text] [Related]
9. Inhibition of oral carcinogenesis by a protease inhibitor. Messadi DV, Billings P, Shklar G, Kennedy AR. J Natl Cancer Inst; 1986 Mar 26; 76(3):447-52. PubMed ID: 3081747 [Abstract] [Full Text] [Related]
10. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29. Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A. Arch Med Res; 2014 Aug 26; 45(6):455-61. PubMed ID: 25014623 [Abstract] [Full Text] [Related]
11. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans. Evans SM, Van Winkle T, Szuhaj B, Michel KE, Kennedy AR. Radiat Res; 1992 Nov 26; 132(2):259-62. PubMed ID: 1438709 [Abstract] [Full Text] [Related]
12. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean. Sadeghalvad M, Mohammadi-Motlagh HR, Karaji AG, Mostafaie A. J Biochem Mol Toxicol; 2019 Dec 26; 33(12):e22406. PubMed ID: 31593353 [Abstract] [Full Text] [Related]
13. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL. Cancer Epidemiol Biomarkers Prev; 2000 Jan 26; 9(1):43-7. PubMed ID: 10667462 [Abstract] [Full Text] [Related]
14. Acute effects of the Bowman-Birk protease inhibitor in mice. Oreffo VI, Billings PC, Kennedy AR, Witschi H. Toxicology; 1991 Jan 26; 69(2):165-76. PubMed ID: 1949045 [Abstract] [Full Text] [Related]
15. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model. Kobayashi H, Fukuda Y, Yoshida R, Kanada Y, Nishiyama S, Suzuki M, Kanayama N, Terao T. Int J Cancer; 2004 Nov 10; 112(3):519-24. PubMed ID: 15382080 [Abstract] [Full Text] [Related]
16. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR. Nutr Cancer; 2002 Nov 10; 43(2):167-73. PubMed ID: 12588697 [Abstract] [Full Text] [Related]
17. Gastric retention and stability of lipidized Bowman-Birk protease inhibitor in mice. Wang J, Shen WC. Int J Pharm; 2000 Aug 25; 204(1-2):111-6. PubMed ID: 11011993 [Abstract] [Full Text] [Related]
18. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. St Clair WH, Billings PC, Carew JA, Keller-McGandy C, Newberne P, Kennedy AR. Cancer Res; 1990 Feb 01; 50(3):580-6. PubMed ID: 2297699 [Abstract] [Full Text] [Related]
19. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro. Yavelow J, Collins M, Birk Y, Troll W, Kennedy AR. Proc Natl Acad Sci U S A; 1985 Aug 01; 82(16):5395-9. PubMed ID: 3860869 [Abstract] [Full Text] [Related]
20. Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice. Wan XS, Ware JH, Zhang L, Newberne PM, Evans SM, Clark LC, Kennedy AR. Prostate; 1999 Dec 01; 41(4):243-52. PubMed ID: 10544297 [Abstract] [Full Text] [Related] Page: [Next] [New Search]